You have 9 free searches left this month | for more free features.

Intestinal Potential Difference

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Kidney Diseases, Inflammation Trial in United States (Ziltivekimab)

Completed
  • Chronic Kidney Diseases
  • Inflammation
  • Ziltivekimab
  • Birmingham, Alabama
  • +48 more
Jul 6, 2021

SARS-CoV-2 Acute Respiratory Disease, Myalgic Encephalomyelitis, Chronic Fatigue Syndrome Trial in San Diego (Extension for

Recruiting
  • SARS-CoV-2 Acute Respiratory Disease
  • +3 more
  • Extension for Community Healthcare Outcomes
  • San Diego, California
    Family Health Centers of San Diego
Dec 20, 2021

Opioid Taper Study

Completed
  • Chronic Pain
  • Opioid Taper Pain perception
  • Philadelphia, Pennsylvania
    Penn Pain Medicine Center Tuttleman Center
Jan 10, 2022

Bipolar Disorder, Bipolar I Disorder, Bipolar Affective Disorder Trial in Chicago (Cognitive Control of Emotion (CCE) Training)

Completed
  • Bipolar Disorder
  • +4 more
  • Cognitive Control of Emotion (CCE) Training
  • Chicago, Illinois
    Rush University Medical Center
Jan 12, 2023

Pancreatic Insufficiency, Cystic Fibrosis Trial in Philadelphia (Omeprazole 40mg Capsule, Placebo oral capsule)

Active, not recruiting
  • Pancreatic Insufficiency
  • Cystic Fibrosis
  • Omeprazole 40mg Capsule
  • Placebo oral capsule
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Apr 11, 2022

S in Preterm nEonates With thromboCyTopenia (PROSPECT)

Recruiting
  • Neonatal Thrombocytopenia
  • +2 more
    • Veldhoven, Brabant, Netherlands
    • +10 more
    Sep 15, 2023

    Prostate Cancer, Positron-Emission Tomography Trial in Fuzhou (68Ga-PSMA-11)

    Recruiting
    • Prostate Cancer
    • Positron-Emission Tomography
    • Fuzhou, Fujian, China
      Department of Nuclear Medicine, First Affiliated Hospital of Fuj
    Apr 2, 2021

    Hepatocellular Carcinoma Trial (biological, drug, other)

    Completed
    • Hepatocellular Carcinoma
    • Pembrolizumab
    • +2 more
    • (no location specified)
    Aug 30, 2022

    Platelet Adhesion in the Pathobiology of Aortic Stenosis

    Not yet recruiting
    • Aortic Valve Stenosis
    • Echocardiogaphy
    • Charlottesville, Virginia
      University of Virginia
    Sep 19, 2022

    Coronary Artery Disease Trial (Lansoprazole 15 mg)

    Not yet recruiting
    • Coronary Artery Disease
    • Lansoprazole 15 mg
    • (no location specified)
    Apr 6, 2023

    Climate Change, Food Preferences Trial in Ann Arbor (Taste-focused labels, Carbon impact labels, Changing default menu options)

    Completed
    • Climate Change
    • Food Preferences
    • Taste-focused labels
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan
    Jan 11, 2023

    Cancer in Remission (Any Type or Stage), Depression, Anxiety Trial in Chicago (Repetitive Transcranial Magnetic Stimulation

    Active, not recruiting
    • Cancer in Remission (Any Type or Stage)
    • +2 more
    • Repetitive Transcranial Magnetic Stimulation (rTMS)
    • Chicago, Illinois
      Northwestern University
    Jan 11, 2023

    CGRP Inhibition, Autonomic Function, and Migraine

    Recruiting
    • Episodic Migraine
    • Chronic Migraine
    • Vienna, Austria
      Medical University of Vienna
    Apr 8, 2022

    Protein Deficiency Trial (PROTEIN SUPPLEMENTATION)

    Completed
    • Protein Deficiency
    • PROTEIN SUPPLEMENTATION
    • (no location specified)
    Apr 26, 2021

    Gingival Disease, Oral Disease Trial in Giza (Oral Health Educational Program)

    Completed
    • Gingival Disease
    • Oral Disease
    • Oral Health Educational Program
    • Giza, Egypt
      New Giza University
    Jul 27, 2021

    Shock, Septic Trial in Worldwide (nangibotide low dose, nangibotide high dose, )

    Active, not recruiting
    • Shock, Septic
    • nangibotide low dose
    • +2 more
    • Bruxelles, Belgium
    • +42 more
    Sep 19, 2022

    SSVEP Evaluation of Brain Function

    Active, not recruiting
    • Mild Traumatic Brain Injury
    • SSVEP Device
    • SCAT5
    • Sydney, Australia
      Headsafe
    Nov 6, 2022

    Chronic Depression, Persistent Depressive Disorder, Recurrent Major Depression Trial (Psychotherapy)

    Completed
    • Chronic Depression
    • +2 more
    • Psychotherapy
    • (no location specified)
    Feb 2, 2022

    Endoscopy, Gastrointestinal Trial in Beijing

    Active, not recruiting
    • Endoscopy, Gastrointestinal
      • Beijing, China
        Dongyang Liu
      Feb 4, 2021

      Childhood Apraxia of Speech: Experience Dependent Changes

      Enrolling by invitation
      • Childhood Apraxia of Speech
      • PROMPT- treatment
      • LNSOM-treatment
      • Marina di Pisa-Tirrenia-Calambrone, Toscana, Italy
        IRCCS Fondazione Stella Maris
      Mar 28, 2022

      Trichuriasis Trial in Kampala (IVM (200 µg/kg) + ALB (400 mg), ALB (400mg))

      Not yet recruiting
      • Trichuriasis
      • IVM (200 µg/kg) + ALB (400 mg)
      • ALB (400mg)
      • Kampala, Uganda
        Vector Borne & Neglected Tropical Disease Control Division, Mini
      Sep 7, 2023

      Hearing Loss Trial in Karachi (pictures, video, control)

      Completed
      • Hearing Loss
      • pictures
      • +2 more
      • Karachi, Sindh, Pakistan
        Ida Rieu College For Blind And Deaf
      Nov 8, 2021

      Spondylolisthesis, Lumbar Disc Herniation, Lumbar Spinal Stenosis Trial in Ubbergen (Ropivacaine Hydrochloride Injection, Sodium

      Recruiting
      • Spondylolisthesis
      • +10 more
      • Ropivacaine Hydrochloride Injection
      • Sodium chloride
      • Ubbergen, Gelderland, Netherlands
        Sint Maartenskliniek
      Jun 13, 2022

      Obesity Trial in Milan (Concurrent Training, Strength Training, Aerobic training)

      Recruiting
      • Obesity
      • Concurrent Training
      • +2 more
      • Milan, Italy
        Istituto Auxologico Italiano IRCCS
      Mar 3, 2023

      Heart Failure Trial (Bis-Hexanoyl (R)-1,3-Butanediol, Placebo)

      Not yet recruiting
      • Heart Failure
      • Bis-Hexanoyl (R)-1,3-Butanediol
      • Placebo
      • (no location specified)
      Mar 2, 2023